ConductScience.org, home

Paper · 36920689

Pseudotyped Viruses.

Wang Y and 8 others. Adv Exp Med Biol, 2023. Cited by 12 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pseudotyped Viruses. Papers, record 36920689. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36920689

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pseudotyped Viruses.
PubMed
Journal
Adv Exp Med Biol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
1.12
iCite
Revised in PubMed
2023-03-20
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang YYouchun
2Zhou ZZehua
3Wu XXi
4Li TTao
5Wu JJiajing
6Cai MMeina
7Nie JJianhui
8Wang WWenbo
9Cui ZZhimin

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Viral Envelope ProteinsMajor topic
Viral PseudotypingMajor topic
Antibodies, Neutralizing
Virus Internalization
Genetic Vectors

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References134

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133,893,470Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays.Nat Protoc2021https://conductscience.org/library/papers/33893470PubMed
232,207,377Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2.Emerg Microbes Infect2020https://conductscience.org/library/papers/32207377PubMed
332,978,602Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay.Nat Protoc2020https://conductscience.org/library/papers/32978602PubMed
412,459,334No false start for novel pseudotyped vectors.Curr Opin Biotechnol2002https://conductscience.org/library/papers/12459334PubMed
59,765,382A third-generation lentivirus vector with a conditional packaging system.J Virol1998https://conductscience.org/library/papers/9765382PubMed
611,892,253Lentiviral vectors derived from simian immunodeficiency virus.Curr Top Microbiol Immunol2002https://conductscience.org/library/papers/11892253PubMed
79,658,096Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors.J Virol1998https://conductscience.org/library/papers/9658096PubMed
823,818,621BET proteins promote efficient murine leukemia virus integration at transcription start sites.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23818621PubMed
924,501,411Enhancers are major targets for murine leukemia virus vector integration.J Virol2014https://conductscience.org/library/papers/24501411PubMed
1025,072,693BET-independent MLV-based Vectors Target Away From Promoters and Regulatory Elements.Mol Ther Nucleic Acids2014https://conductscience.org/library/papers/25072693PubMed

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42,126,187A CRISPR activation screen identifies CH25H as a restriction factor against influenza viruses by targeting accessible cholesterol.Emerg Microbes Infect2026https://conductscience.org/library/papers/42126187PubMed
41,011,810Establishment of a Pseudovirus-Based Golden Hamster Model for the Attachment and Entry Stages of Hendra Virus Infection and Evaluation of Protective Immunity.Pathogens2025https://conductscience.org/library/papers/41011810PubMed
40,871,289Exploring the Use of Viral Vectors Pseudotyped with Viral Glycoproteins as Tools to Study Antibody-Mediated Neutralizing Activity.Microorganisms2025https://conductscience.org/library/papers/40871289PubMed
40,419,646Nonviral protein cages as tools to decipher and combat viral threats.Npj Viruses2025https://conductscience.org/library/papers/40419646PubMed
39,747,691Receptor-binding proteins from animal viruses are broadly compatible with human cell entry factors.Nat Microbiol2025https://conductscience.org/library/papers/39747691PubMed
39,599,905SARS-CoV-2 Neutralizing Antibodies 2.0.Viruses2024https://conductscience.org/library/papers/39599905PubMed
39,512,237A validated and standardized pseudotyped microneutralization assay as a safe and powerful tool to measure LASSA virus neutralising antibodies for vaccine development and comparison.F1000Res2024https://conductscience.org/library/papers/39512237PubMed
38,525,106Development of a SARS-CoV-2 neutralization assay based on a pseudotyped virus using a HIV system.MedComm (2020)2024https://conductscience.org/library/papers/38525106PubMed
38,398,205Transduction Efficiency of Zika Virus E Protein Pseudotyped HIV-1gfp and Its Oncolytic Activity Tested in Primary Glioblastoma Cell Cultures.Cancers (Basel)2024https://conductscience.org/library/papers/38398205PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36920689

GET https://conductscience.org/api/papers/v1/36920689/references?page=2